Screener
R&D at other companies
Other financials
Where this comes from
Reported directly by BILL Holdings in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: BILL Holdings’s 10-Q, filed May 8, 2026.
- Filed
- May 7, 2026, 8:00 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-032387
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 | Nine Months Ended March 31, 2026 | Nine Months Ended March 31, 2025 |
|---|---|---|---|---|
| Total cost of revenue | 74,708 | 67,212 | 235,300 | 198,515 |
| Gross profit | 331,855 | 291,005 | 981,674 | 880,706 |
| Operating expenses | ||||
| Research and development | 74,385 | 86,540 | 237,480 | 250,009 |
| Sales and marketing | 153,226 | 136,758 | 457,880 | 395,614 |
| General and administrative | 72,286 | 73,851 | 228,700 | 211,744 |
| Provision for expected credit losses | 18,834 | 14,945 | 57,554 | 56,964 |
| Depreciation and amortization (1) | 8,479 | 7,857 | 24,929 | 24,728 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is BILL Holdings's R&D?
- BILL Holdings (BILL) reported R&D of $74.39M in Q1 2026.
- How has BILL Holdings's R&D changed year-over-year?
- BILL Holdings's R&D decreased by 14.0% year-over-year, from $86.54M to $74.39M.
- What is the long-term trend for BILL Holdings's R&D?
- Over 3 years (2022 to 2025), BILL Holdings's R&D has grown at a 15.7% compound annual growth rate (CAGR), from $219.82M to $340.06M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about BILL Holdings's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude